1 citations
,
December 2013 in “Turkderm” This article discusses the increasing use of plant and plant extracts during pregnancy and lactation, highlighting user perceptions of their benefits and safety but does not present new research findings.
20 citations
,
April 2021 in “Journal of Womens Health” This guideline provides evidence-based recommendations for prescribing testosterone therapy to women with hypoactive sexual desire disorder, noting a moderate therapeutic benefit but highlighting limited data and regulatory challenges.
3 citations
,
January 2015 in “Social Science Research Network” This study discusses the role of physicians and pharmaceutical companies as entrepreneurial actors in off-label drug use, arguing they may advance patient care more quickly than regulatory agencies.
3 citations
,
January 1996 in “PubMed” This review discusses the early stages of pharmaceutical product promotion on the internet and highlights the current lack of specific regulatory guidance for such advertising.
13 citations
,
May 2006 in “Annals of Saudi Medicine” The researchers reported substantial discrepancies in prescribing information between generic drugs marketed in Saudi Arabia and standard references, indicating a need for regulatory improvements to ensure accuracy and patient safety.